S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
S&P 500   4,229.45
DOW   33,002.38
QQQ   354.92
3 Drone Stocks That Can Lift Your Portfolio Higher
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
3 Quality Stocks On Track for Significant Dividend Increases
International Paper's 5% Yield Offers Big Value
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
Warren Buffett's company dumps another 5 million shares of printer maker HP
How You Can Beat the Yields on near 5% Treasuries, plus Upside
[BREAKING] New "Living Missile" to Replace Nuclear Missiles (Ad)
This Is One of the Top-Rated and Most-Upgraded Stocks
5 Economic Trends That Will Drive The Market In Q4
OTCMKTS:NEVPF

Abliva AB (publ) (NEVPF) Stock Forecast, Price & News

Compare
Today's Range
N/A
50-Day Range
$0.01
▼
$0.01
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ProfileChartCompetitorsHeadlinesShort Interest

NEVPF stock logo

About Abliva AB (publ) (OTCMKTS:NEVPF) Stock

Abliva AB (publ), a clinical-stage biotech company, develops medicines for the treatment of primary mitochondrial diseases. The company is developing KL1333 that is in Phase 2/3 clinical trials for the chronic treatment of primary mitochondrial diseases; NV354, which is in the preparation for clinical trials for the treatment of primary mitochondrial diseases with Complex I deficiency; and NeuroSTAT that is in Phase 1b/2a clinical study for traumatic brain injury. It has collaboration agreements with Isomerase, Yungjin Pharm, University of Pennsylvania, Children's Hospital of Philadelphia, and Oroboros Instruments. The company was formerly known as NeuroVive Pharmaceutical AB (publ) and changed its name to Abliva AB (publ) in May 2020. Abliva AB (publ) was incorporated in 2000 and is headquartered in Lund, Sweden.


NEVPF Stock News Headlines

October 3, 2023 | investing.com
Interfox Resources publ AB (IFOX)
October 14, 2022 | investing.com
Cell Impact publ AB (CELLI)
October 4, 2023 | Legacy Research (Ad)
Man Gets Into a Self-Driving Tesla… What Happens Next will Shock Everyone (Video)
“Hi, I’m Teeka Tiwari...I’m about to get in this Tesla and drive up to a facility just a few miles from here to show you what could be the secret behind Elon Musk’s new AI project… What happens next will shock you…”
January 20, 2022 | nasdaq.com
Abliva AB (publ) (NEVPF)
November 28, 2020 | finanznachrichten.de
BioInvent strengthens Investor Relations
June 28, 2020 | finance.yahoo.com
Venture Fund Manager Has $100 Million for Startups Run by Women
April 7, 2020 | finance.yahoo.com
Here's Why NeuroVive Pharmaceutical (STO:NVP) Must Use Its Cash Wisely
February 19, 2020 | seekingalpha.com
NeuroVive Pharmaceutical AB reports Q4 results
October 4, 2023 | Behind the Markets (Ad)
BREAKING: The truth about war with China
Foreign Affairs reports, "China is Now in a Prewar Tempo of Political and Military Preparations." China has one goal: take control of Taiwan, and an invasion could happen any day. I've identified 5 investments I believe are in immediate danger. But you can get out of them now - before it's too late.
February 4, 2020 | finance.yahoo.com
Investors Who Bought NeuroVive Pharmaceutical (STO:NVP) Shares Five Years Ago Are Now Down 98%
December 20, 2019 | markets.businessinsider.com
NeuroVive Completes Recruitment in the Second Part of its Ongoing KL1333 Clinical Phase Ia/b Study
December 16, 2019 | seekingalpha.com
NeuroVive settles dispute with CicloMulsion AG
December 16, 2019 | finance.yahoo.com
NeuroVive Announces Settlement in Dispute With CicloMulsion AG
December 4, 2019 | ca.finance.yahoo.com
How Much Did NeuroVive Pharmaceutical AB's (STO:NVP) CEO Pocket Last Year?
December 4, 2019 | finance.yahoo.com
How Much Did NeuroVive Pharmaceutical AB's (STO:NVP) CEO Pocket Last Year?
October 29, 2019 | finance.yahoo.com
Have Insiders Been Buying NeuroVive Pharmaceutical AB (STO:NVP) Shares?
September 26, 2019 | finance.yahoo.com
We Think NeuroVive Pharmaceutical (STO:NVP) Needs To Drive Business Growth Carefully
August 23, 2019 | finance.yahoo.com
How Does Investing In NeuroVive Pharmaceutical AB (STO:NVP) Impact The Volatility Of Your Portfolio?
May 22, 2019 | finance.yahoo.com
Catalyst Pharma (CPRX) Rides on Successful Launch of Firdapse
May 21, 2019 | finance.yahoo.com
NeuroVive Pharmaceutical AB Interim Report January - March 2019
March 25, 2019 | finance.yahoo.com
NeuroVive Pharmaceutical AB Publishes 2018 Annual Report
March 7, 2019 | finance.yahoo.com
NeuroVive Receives SEK 28.2 Million in a Directed New Share Issue
February 21, 2019 | finance.yahoo.com
NeuroVive Enters Commercial Partnership With Oroboros Instruments on Mitochondrial Medicine Research Compounds
See More Headlines
Receive NEVPF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Abliva AB (publ) and its competitors with MarketBeat's FREE daily newsletter.

NEVPF Company Calendar

Today
10/03/2023
Fiscal Year End
12/31/2023
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:NEVPF
CUSIP
N/A
CIK
N/A
Web
www.neurovive.com
Phone
(646) 275-6220
Fax
46-4-688-883-48
Employees
8
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
$20,000.00
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.01 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
403,010,000
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2023 Cover
The Best High-Yield Dividend Stocks for 2023

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Dr. Ellen K. Donnelly Ph.D. (Age 49)
    Chief Exec. Officer
  • Ms. Catharina Jz Johansson (Age 56)
    Deputy CEO, CFO & VP of Investor Relations
  • Dr. Eskil Elmér (Age 53)
    Chief Scientific Officer & VP of Discovery
  • Daniel Schale
    Director of Communications
  • Dr. Magnus Hansson (Age 47)
    Chief Medical Officer and VP of Preclinical & Clinical Devel.
  • Mr. Dag Nesse
    VP of Clinical Operations
  • Dr. Lars Vedin
    Consultant

Key Competitors

View All Competitors













NEVPF Stock - Frequently Asked Questions

What is Abliva AB (publ)'s stock symbol?

Abliva AB (publ) trades on the OTCMKTS under the ticker symbol "NEVPF."

How do I buy shares of Abliva AB (publ)?

Shares of NEVPF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How much money does Abliva AB (publ) make?

Abliva AB (publ) (OTCMKTS:NEVPF) has a market capitalization of $0.00 and generates $20,000.00 in revenue each year.

How can I contact Abliva AB (publ)?

Abliva AB (publ)'s mailing address is MEDICON VILLAGE SCHEELEVAGEN 2, LUND V7, 22381. The official website for the company is www.neurovive.com. The company can be reached via phone at (646) 275-6220, via email at ir@abliva.com, or via fax at 46-4-688-883-48.

This page (OTCMKTS:NEVPF) was last updated on 10/4/2023 by MarketBeat.com Staff

My Account -